secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2026-06-17T20:05:19+00:00
Accession:  0001493152-26-029081
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical appoints Chairman Stavros Vizirgianakis as Executive Chairman; grants 450,000 RSUs
--------------------------------------------------------------------------------

- Stavros Vizirgianakis appointed Executive Chairman effective June 11, 2026; will lead strategic initiatives and investor engagement.
- Receives 450,000 RSUs: 150,000 vest immediately, 150,000 over 12 months starting year 1, 150,000 over 12 months starting year 2.
- No cash compensation for the role; only expense reimbursement.
- Unvested RSUs fully accelerate upon a Change of Control.
- Vizirgianakis will not be an officer or employee, nor designated as an executive officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000149315226029081/0001493152-26-029081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000149315226029081/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer